Contract analysis
Clause-by-clause risk read on any document of the firm. Pick a contract, or open any document from a matter.
Contract analysis / template-speaker-program-agreement.docx
template-speaker-program-agreement.docx
High · 3
Medium · 6
Standard · 1
ARTICLE 1 — DEFINITIONS
ARTICLE 1 — DEFINITIONS As used in this Agreement, the following terms shall have the meanings set forth below. Capitalized terms used but not defined in this Article 1 shall have the meanings ascribed to them elsewhere in this Agreement. 1.1 "Approved Slide Deck" means the presentation materials prepared, reviewed, and approved by the Company's Medical-Legal-Regulatory (MLR) Committee for use in Speaker Programs, in
ARTICLE 2 — ENGAGEMENT AND SCOPE OF SERVICES
High
⚑ Non-compete / exclusivity restraint
ARTICLE 2 — ENGAGEMENT AND SCOPE OF SERVICES 2.1 Engagement. The Company hereby engages Speaker, and Speaker hereby accepts the engagement, to serve as a speaker at Company-sponsored Speaker Programs during the Term, subject to and in accordance with the terms and conditions of this Agreement. Speaker's engagement is non-exclusive, and nothing in this Agreement shall prevent the Company from engaging other speakers o
ARTICLE 3 — NEEDS ASSESSMENT AND PROGRAM APPROVAL
Medium
⚑ Liability cap to check against exposure
ARTICLE 3 — NEEDS ASSESSMENT AND PROGRAM APPROVAL 3.1 Legitimate Business Need Requirement. Each individual Speaker Program must be supported by a documented legitimate business need assessment, prepared by a member of the Company's US Commercial Operations team or Medical Affairs department, and approved by the Compliance Officer (or the Compliance Officer's designee) prior to scheduling the program or extending any
ARTICLE 4 — SPEAKER TRAINING PREREQUISITE
Medium
⚑ Notice / time limit to track
ARTICLE 4 — SPEAKER TRAINING PREREQUISITE 4.1 Mandatory Training. Prior to delivering any Speaker Program under this Agreement, Speaker must successfully complete the Company's Speaker Training program in its entirety. The Speaker Training program is designed to ensure that Speaker has a thorough understanding of the Pulsar™ CRM System, the applicable regulatory and compliance framework, and the Company's expectation
ARTICLE 5 — COMPENSATION
Medium
⚑ Liability cap to check against exposure
ARTICLE 5 — COMPENSATION 5.1 Honoraria. As full compensation for Speaker's services in delivering Speaker Programs under this Agreement, the Company shall pay Speaker the following honoraria: (a) Live Program: Speaker shall receive an honorarium of One Thousand Five Hundred Dollars ($1,500.00) per Live Program delivered in accordance with the terms of this Agreement. (b) Virtual Program: Speaker shall receive an hono
ARTICLE 6 — EXPENSES AND MEALS
Medium
⚑ Liability cap to check against exposure
ARTICLE 6 — EXPENSES AND MEALS 6.1 Reimbursable Expenses. For Live Programs that require Speaker to travel away from Speaker's principal practice location, the Company may reimburse Speaker for reasonable, documented, and pre-approved out-of-pocket travel expenses actually incurred by Speaker in direct connection with the Speaker Program. Reimbursable expenses are limited to the following categories: (a) Airfare: Eco
ARTICLE 7 — VENUE REQUIREMENTS AND RESTRICTIONS
ARTICLE 7 — VENUE REQUIREMENTS AND RESTRICTIONS 7.1 Approved Venues. Speaker Programs shall be held only at venues that are conducive to a professional, educational setting and that are selected based on their suitability for the educational objectives of the program rather than for entertainment, recreational, or social purposes. Approved venue types include, without limitation: (a) Hospital or healthcare facility c
ARTICLE 8 — CONTENT RESTRICTIONS AND PROMOTIONAL COMPLIANCE
Medium
⚑ Liability cap to check against exposure
ARTICLE 8 — CONTENT RESTRICTIONS AND PROMOTIONAL COMPLIANCE 8.1 Approved Slide Deck Only. Speaker shall use only the current version of the Approved Slide Deck provided by the Company for each Speaker Program. Speaker acknowledges that the Approved Slide Deck has been prepared and reviewed by the Company's MLR Committee to ensure compliance with FDA regulations, the Cleared Indications, and the Company's promotional
ARTICLE 9 — COMPLIANCE OBLIGATIONS
High
⚑ Penalty / liquidated damages
ARTICLE 9 — COMPLIANCE OBLIGATIONS 9.1 Anti-Kickback Statute Compliance. Speaker acknowledges that this Agreement is structured and intended to comply with the federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)) and, in particular, with the personal services and management contracts safe harbor set forth at 42 C.F.R. § 1001.952(d). Speaker acknowledges that the Anti-Kickback Statute prohibits the knowing and will
ARTICLE 10 — TERM AND TERMINATION
High
⚑ Unilateral / for-convenience termination
ARTICLE 10 — TERM AND TERMINATION 10.1 Term. This Agreement shall be effective as of the Effective Date and shall continue for a period of [Insert — e.g., one (1) year] from the Effective Date, unless earlier terminated in accordance with the provisions of this Article 10 (the "Term"). Upon expiration of the initial Term, this Agreement may be renewed for additional successive periods of [Insert — e.g., one (1) year]
ARTICLE 11 — PHYSICIAN PAYMENTS SUNSHINE ACT / OPEN PAYMENTS REPORTING
Standard
⚑ Commercial term
ARTICLE 11 — PHYSICIAN PAYMENTS SUNSHINE ACT / OPEN PAYMENTS REPORTING 11.1 Reporting Obligation. Speaker acknowledges that the Company is an "applicable manufacturer" as defined under the Physician Payments Sunshine Act (42 U.S.C. § 1320a-7h) and the implementing regulations promulgated by CMS at 42 C.F.R. Part 403, Subpart I. As an applicable manufacturer, the Company is required by federal law to collect, track, a
ARTICLE 12 — CONFIDENTIALITY
Medium
⚑ Notice / time limit to track
ARTICLE 12 — CONFIDENTIALITY 12.1 Confidential Information. Speaker agrees to maintain in strict confidence all non-public, proprietary, or confidential information disclosed by the Company to Speaker in connection with this Agreement or Speaker's engagement hereunder (collectively, "Confidential Information"). Confidential Information includes, without limitation, the Company's business strategies, marketing plans,
ARTICLE 13 — REPRESENTATIONS AND WARRANTIES
ARTICLE 13 — REPRESENTATIONS AND WARRANTIES 13.1 Speaker Representations and Warranties. Speaker represents and warrants to the Company, as of the Effective Date and at all times during the Term of this Agreement, as follows: (a) Speaker holds a current, valid, and unrestricted license to practice medicine in the State(s) of [Insert State(s)] and is in good standing with the applicable state medical board(s); (b) Spe